The case for testing Pfizer’s Paxlovid for treating long COVID
Two long COVID patients recover after Paxlovid treatment Side effects, safety issues need to be studied CHICAGO, April 18 (Reuters) – Reports of two patients who found relief from long COVID after taking Pfizer Inc’s (PFE.N) antiviral Paxlovid, including a researcher who tested it on herself, provide intriguing evidence for clinical trials to help those …
The case for testing Pfizer’s Paxlovid for treating long COVID Read More »